Reference is made to the stock exchange notice from Vistin Pharma ASA earlier today, 22 March 2018, regarding a subsequent repair issue of approximately NOK 50 million. Key information for the subsequent repair issue is described below.
---
Date on which the terms and conditions of the subsequent repair issue were announced: 22 March 2018
Last day including right: 22 March 2018
Ex-date: 23 March 2018
Record Date: 26 March 2018
Date of approval: 9 May 2018
Maximum number of new shares: 4,464,286
Subscription price: NOK 11.20
Will the rights be listed - yes/no: No
Other information: The subsequent repair issue is subject to approval by the annual general meeting of Vistin Pharma ASA and approval and publication of a prospectus, expected to take place on or about 11 May 2018.
This information is published in accordance with the requirements of the Continuing Obligations.